Navigation Links
Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology
Date:3/6/2008

New relationship between NanoHorizons and Hill-Rom delivers patient support

systems enhanced with revolutionary antimicrobial technology

BATESVILLE, Ind., March 6 /PRNewswire-FirstCall/ -- Hill-Rom and NanoHorizons, Inc. today announced an agreement to incorporate NanoHorizon's antimicrobial technology into Hill-Rom's patient support surfaces. This technology, to be branded as "nanoAg+ (TM) with SmartSilver(TM)", will bring new levels of protection against institutionally-borne pathogens.

Hill-Rom, the medical technology subsidiary of Hillenbrand Industries, Inc. (NYSE: HB), is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry. NanoHorizons, a leader in the field of advanced nanomaterials, engineers and delivers permanent antimicrobial solutions under the SmartSilver(TM) brand.

"Our relationship with NanoHorizons is a natural next step in Hill-Rom's commitment to leveraging and integrating differentiated external technologies to help deliver enhanced outcomes for patients and their caregivers," said Peter Soderberg, president and CEO of Hillenbrand Industries and Hill-Rom. "Caregivers and health care administrators are looking for solutions on how they can prevent health care-associated infections. We anticipate that our relationship with NanoHorizons will yield a comprehensive portfolio of products with built-in, long-lasting antimicrobial protection. Given how important this issue is for the health care industry, we aim to offer a nanoAg+ with SmartSilver option on all of our preventative and therapeutic surface products by the end of 2009."

Infection control is one of the critical issues in health care today. In its 2003 Guidelines for Environmental Infection Control in Health Care Facilities, the Centers for Disease Control and Prevention (CDC) has identified that, "Contaminated textiles and fabrics often contain high numbers of microorganisms from body substances, including blood, skin, stool, urine, vomitus, and other body tissues and fluids."(1) Further, the CDC estimates that health care-associated infections account for an estimated 1.7 million infections and 99,000 associated deaths each year in US hospitals.(2)

Silver is one of nature's most powerful antimicrobial agents. In lab tests, it has been found to be 99.9 percent effective in the reduction of surface bacteria and viruses including the virulent staph infection known as Methicillin-resistant Staphylococcus aureus (MRSA). Unlocking silver's properties for use as a protector is a specialized scientific field, an area where NanoHorizons scientists have been leaders. Unlike other silver technologies being offered today, NanoHorizons has pioneered the specific use of nanotechnology to create and manipulate materials that are smaller than 100 nanometers in size. When applied to coatings, fabrics and laminates, nanotechnology allows the silver to cover an area more effectively and last much longer than any other antimicrobial coating, according to Dr. Stephen Fonash, Kunkle Chair of Engineering Science at Penn State University and Co- Founder of NanoHorizons.

To bring the enhanced benefits of SmartSilver into the hospital and other caregiver settings through application to beds and therapeutic surfaces requires the special expertise of Hill-Rom working with NanoHorizons to create nanoAg+(TM). Together, these two companies will soon introduce nanoAg+ with SmartSilver, a vital new solution for the health care environment.

"The SmartSilver brand is succeeding in a wide variety of fields with partners who share a common interest in delivering leading-edge antimicrobial product protection to today's marketplace," said Daniel Hayes, president and chief executive officer of NanoHorizons. "Hill-Rom is an ideal partner for advanced medical equipment applications, given their longstanding commitment to innovation and their unwavering dedication to improved patient outcomes."

ABOUT NANOHORIZONS, INC.

NanoHorizons, Inc., (http://www.nanohorizons.com) with its solid foundation in applied chemistry and engineering, is a leader in the emerging field of practical nanotechnology. NanoHorizon's SmartSilver(TM) antimicrobial offers permanent bacterial control for textiles, medical devices and industrial materials. NanoHorizons is privately held and headquartered in State College, PA. The company works closely with customers from its R&D laboratory, manufacturing facility, and technical support office adjacent to The Penn State University.

ABOUT HILL-ROM.

Hill-Rom, an operating company of Hillenbrand Industries, Inc., is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, and workflow information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom... enhancing outcomes for patients and their caregivers.

Hillenbrand Disclosure Regarding Forward-Looking Statements

Certain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking. It is important to note that forward- looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward- looking statements. Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large national providers and group purchasing organizations, changes in death rates, whether the Company's new products are successful in the marketplace, changes in customers' Medicare reimbursements, collections of accounts receivable, compliance with FDA regulations, antitrust litigation, potential exposure to product liability or other claims, failure of the Company's announced strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, disruptions in the Company's business or other adverse consequences resulting from the planned separation of the Company's two operating companies, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, competition from nontraditional sources in the funeral services business, volatility of the Company's investment portfolio, increased costs or unavailability of raw materials, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters. For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the period ended September 30, 2007 and in Amendment 1 to the Batesville Holdings, Inc., Form 10. The Company assumes no obligation to update or revise any forward-looking statements.

(1) http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/Enviro_guide_03.pdf

(2) http://www.cdc.gov/ncidod/dhqp/hai.html

Hill-Rom Media:

Lauren Green-Caldwell, Director, Corporate Communications & Public Relations
Phone: 812-934-8692

Email: lauren.green-caldwell@hillenbrand.com

Hill-Rom Investor Relations:

Blair A. (Andy) Rieth, Jr., Vice President, Investor Relations, Corporate Communications & Global Brand Development, Hillenbrand Industries, Inc.

Phone: 812-931-2199

Email: andy.rieth@hillenbrand.com


'/>"/>
SOURCE Hillenbrand Industries, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
2. Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center
3. Hill-Rom Introduces Fashionable, Affordable Bed for Home and Post-Acute Care Patients
4. Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery
5. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
6. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
7. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
8. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
9. ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
10. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
11. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced that ... donate to Give To Cure’s campaign that is crowdfunding clinical trials to help find ... share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion in ...
(Date:2/5/2016)... ... , ... At its annual meeting held last week, the American Parkinson Disease ... of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We are pleased ... APDA President and CEO. “Pat has tirelessly served APDA since 2001 when he was ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... CitiDent, announces that it is now welcoming orthodontist, Dr. Amanda Cheng, to ... a complete range of oral health care, including general dentistry, cosmetic treatments, periodontics, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Health and wellness is a topic ... in the event they are experiencing an illness. Migraines are a severe form of ... afflicted with migraines would not wish the pain on their worst enemy, the feeling ...
(Date:2/5/2016)... ... , ... Calls Blacklist has just been updated by mobile app developer Vlad ... has fixed known bugs within the app. Calls Blacklist allows its users to only ... any of their device’s battery power or memory. It provides a powerful call blocker ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Edwards Lifesciences ... patient-focused innovations for structural heart disease and critical care ... accelerated share repurchase (ASR) agreement with Morgan Stanley & ... stock.  This repurchase is part of the Company,s previously ... the Company,s common stock.  --> ...
(Date:2/4/2016)... 2016   Bernstein Liebhard LLP today announced that ... States District Court for the District of Arizona ... of all persons or entities who purchased common shares of ... ) from March 3, 2015 through January 25, 2016 (the ... officers with violations of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... LODI, N.J. , Feb. 4, 2016  Montoya ... Pinnacle Professional in the field of Pharmaceuticals. Montoya is ... . ... and supplies, Becton Dickinson provides healthcare institutions, ... medical equipment throughout fifty countries across the globe. ...
Breaking Medicine Technology: